This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Kyowa Kirin International plc
Kyowa Kirin International plc, a subsidiary of Kyowa Kirin Co., Ltd., is a prominent biopharmaceutical company headquartered in Great Britain. Established in 1949, the company has made significant strides in the healthcare sector, focusing on innovative treatments in areas such as oncology, nephrology, and immunology. With a strong presence in Europe and a commitment to research and development, Kyowa Kirin is renowned for its unique biologics and small molecule therapies. Their flagship products, including advanced monoclonal antibodies, are distinguished by their targeted mechanisms and patient-centric approach. Kyowa Kirin's dedication to scientific excellence has positioned it as a leader in the biopharmaceutical industry, achieving notable milestones in drug development and regulatory approvals. The company continues to enhance its market position through strategic partnerships and a robust pipeline of therapies aimed at addressing unmet medical needs.
DitchCarbon Score
How does Kyowa Kirin International plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kyowa Kirin International plc's score of 66 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kyowa Kirin International plc, headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Kyowa Kirin Co., Ltd., which cascades its climate commitments and initiatives. Kyowa Kirin Co., Ltd. has set various reduction targets, although specific details on these targets are not provided in the available data. The company is involved in several climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are sourced from Kyowa Kirin Co., Ltd. at a cascade level of 1. Additionally, Kyowa Kirin International plc is linked to Kirin Holdings Company, Limited, which is involved in the RE100 and the Race to Zero initiatives at a cascade level of 2. While specific emissions data and reduction targets for Kyowa Kirin International plc are not disclosed, the company's affiliation with its parent organizations suggests a commitment to sustainability and climate action in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 17,244,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 34,687,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kyowa Kirin International plc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
